Tang Ning, Luo Yuanmei, Li Mangui, Zhu Mingchao, Li Dengju
Department of Clinical laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Clinical laboratory, Qingyuan People's Hospital, Qingyuan, China.
Res Pract Thromb Haemost. 2024 Dec 12;9(1):102657. doi: 10.1016/j.rpth.2024.102657. eCollection 2025 Jan.
Current guidelines recommend application of the 99th percentile to determine the cut-off value on at least 120 healthy donors regardless of sex for lupus anticoagulant (LA) ratio of each step. However, a statistically significant difference between the sexes has been found for LA ratio recently.
To clarify whether this sex difference in dilute Russell's viper venom time (DRVVT) exists in various detection systems and the necessity of setting sex-specific cut-off values.
Blood samples from healthy donors were detected on 3 DRVVT detection systems, and the sex-specific cut-offs of DRVVT test were obtained based on the 99th or 97.5th centile of screen, confirm, and normalized ratios (NRs) grouped by sex in each system. One thousand one hundred twenty one female patients with suspected antiphospholipid syndrome (APS) were retrospectively investigated, the APS-associated clinical and laboratory characteristics of female patients stratified by different cut-offs of DRVVT ratio were compared.
The DRVVT NRs of females were significantly lower than those of males on each system. The female patients with DRVVT NR between female-specific and regardless of sex cut-offs had higher positive rates of silica clotting time test and LA retest results after 12 weeks than those with DRVVT NRs lower than female-specific cut-off, there were also more patients who met the APS clinical criteria.
The sex difference of the cut-off value for DRVVT LA test is confirmed on multiple systems, the female-specific cut-off is lower than regardless of sex cut-off and may lead to more female patients being considered as high-risk population for APS.
当前指南建议应用第99百分位数来确定狼疮抗凝物(LA)各步比值的临界值,至少需要120名健康供者,且不考虑性别。然而,最近发现LA比值在性别之间存在统计学显著差异。
明确在各种检测系统中稀释蝰蛇毒时间(DRVVT)的这种性别差异是否存在,以及设定性别特异性临界值的必要性。
在3种DRVVT检测系统上检测健康供者的血样,并根据每个系统中按性别分组的筛查、确认和标准化比值(NR)的第99或第97.5百分位数获得DRVVT试验的性别特异性临界值。回顾性调查1121例疑似抗磷脂综合征(APS)的女性患者,比较不同DRVVT比值临界值分层的女性患者的APS相关临床和实验室特征。
在每个系统上,女性的DRVVT NR均显著低于男性。DRVVT NR处于女性特异性临界值与不考虑性别临界值之间的女性患者,其硅凝时间试验阳性率和12周后LA复测结果高于DRVVT NR低于女性特异性临界值的患者,符合APS临床标准的患者也更多。
多个系统证实了DRVVT LA试验临界值的性别差异,女性特异性临界值低于不考虑性别的临界值,可能导致更多女性患者被视为APS高危人群。